These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20507987)

  • 1. Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.
    Huskens D; Férir G; Vermeire K; Kehr JC; Balzarini J; Dittmann E; Schols D
    J Biol Chem; 2010 Aug; 285(32):24845-54. PubMed ID: 20507987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
    Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
    J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mannan binding lectin is involved in cell-cell attachment in a toxic strain of Microcystis aeruginosa.
    Kehr JC; Zilliges Y; Springer A; Disney MD; Ratner DD; Bouchier C; Seeberger PH; de Marsac NT; Dittmann E
    Mol Microbiol; 2006 Feb; 59(3):893-906. PubMed ID: 16420359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Algal lectins as potential HIV microbicide candidates.
    Huskens D; Schols D
    Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.
    Balzarini J; Van Laethem K; Peumans WJ; Van Damme EJ; Bolmstedt A; Gago F; Schols D
    J Virol; 2006 Sep; 80(17):8411-21. PubMed ID: 16912292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity.
    Hoorelbeke B; Van Damme EJ; Rougé P; Schols D; Van Laethem K; Fouquaert E; Balzarini J
    Retrovirology; 2011 Feb; 8(1):10. PubMed ID: 21314946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of microvirin monomers and oligomers on hepatitis C virus.
    Min YQ; Duan XC; Zhou YD; Kulinich A; Meng W; Cai ZP; Ma HY; Liu L; Zhang XL; Voglmeir J
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28507200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
    Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.
    Balzarini J; Hatse S; Vermeire K; Princen K; Aquaro S; Perno CF; De Clercq E; Egberink H; Vanden Mooter G; Peumans W; Van Damme E; Schols D
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3858-70. PubMed ID: 15388446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.
    Kachko A; Loesgen S; Shahzad-Ul-Hussan S; Tan W; Zubkova I; Takeda K; Wells F; Rubin S; Bewley CA; Major ME
    Mol Pharm; 2013 Dec; 10(12):4590-4602. PubMed ID: 24152340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
    Balzarini J; Van Laethem K; Hatse S; Vermeire K; De Clercq E; Peumans W; Van Damme E; Vandamme AM; Bölmstedt A; Schols D
    J Virol; 2004 Oct; 78(19):10617-27. PubMed ID: 15367629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
    Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
    J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.
    Balzarini J; François KO; Van Laethem K; Hoorelbeke B; Renders M; Auwerx J; Liekens S; Oki T; Igarashi Y; Schols D
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1425-35. PubMed ID: 20047920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the effects of point mutations on the affinity between the cyanobacterial lectin microvirin and high mannose-type glycans present on the HIV envelope glycoprotein.
    Conceição de Souza R; de Medeiros Muniz G; Siqueira AS; de Melo Lima A; da Silva AP; Gonçalves EC; da Silva Gonçalves Vianez Júnior JL
    J Mol Model; 2016 Nov; 22(11):269. PubMed ID: 27771810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.
    Férir G; Huskens D; Noppen S; Koharudin LM; Gronenborn AM; Schols D
    J Antimicrob Chemother; 2014 Oct; 69(10):2746-58. PubMed ID: 24970741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.